News Releases
This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
03 15 2021 Zora Biosciences Oy, a clinical diagnostics company whose mission is to identify robust markers of disease and develop them into high-throughput, health-economic value-added clinical methods,...
-
03 11 2021 - Company to repurchase $900 million of its shares in first half of 2021At a virtual meeting with analysts and investors at its Investor Day, members of the senior management team of Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of...
-
03 08 2021 Quest to acquire Mercy's outreach laboratory business serving providers and patients in Arkansas, Kansas, Missouri and OklahomaQuest Diagnostics (NYSE: DGX), the leading provider of diagnostic information services, and Mercy, one of the nation's most highly integrated, multi-state health care systems, today announced a...
-
03 02 2021 -Quest will remain the exclusive, national clinical reference laboratory and testing provider for BlueCross BlueShield of Western New York and BlueShield of Northeastern New York members for all products-SECAUCUS, N.J., March 2, 2021— BlueCross BlueShield of Western New York and BlueShield of Northeastern New York, two of New York’s leading insurance carriers, and Quest Diagnostics (NYSE:...
-
03 02 2021 Collaboration empowers individuals to access professional medical advice, when and where they want it, for employer-sponsored laboratory and biometric screening98point6, the on-demand digital primary care service that delivers personalized diagnosis, treatment and consultation to patients across the country, today announced a collaboration with Quest...
-
02 24 2021 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today introduced a new COVID-19 testing service that aids in providing insight into an individual's...
-
02 23 2021 --Daniel C. Stanzione to Retire from Board and as Lead Independent DirectorQuest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced changes in the leadership of its Board of Directors. Daniel C. Stanzione,...
-
02 23 2021 -- Quest Diagnostics to Provide Blood Specimen Collection for Galleri Through its Patient Service Centers and Mobile Phlebotomists --MENLO PARK, Calif.-- GRAIL, Inc., a healthcare company whose mission is to detect cancer early, when it can be cured, today announced an agreement with Quest Diagnostics (NYSE: DGX), the leading...
-
02 16 2021 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at Citi's 2021 Healthcare Services, Medtech,...
02 16 2021 - Quest will remain the preferred national clinical reference laboratory and testing provider for EmblemHealth and ConnectiCare members for all productsEmblemHealth, one of the nation's largest non-profit health insurers, and Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, have renewed their...